DyoDelta Biosciences
London-based life sciences advisory firm founded in 2000 that provides strategic and transactional support to pharma, biotech, MedTech and HealthTech companies and to professional investors. Core activities include business development and licensing, capital raising and investor relations, product development planning and clinical strategy, commercialization and distributor network support, executive search, due diligence, valuations and expert witness services.
Industries
Nr. of Employees
small (1-50)
DyoDelta Biosciences
Products
Pharmaceutical Expert Witness Service
Independent expert witness support and consulting for pharmaceutical and biotechnology litigation, licensing disputes, lost revenues, damages determination, and diligence obligations.
Corporate Deals
Assisting companies in Business Development, identifying partners and products, in-licensing and out-licensing, M&A, R&D collaborations, Financing.
Product Licensing
Services to help companies identify products for licensing, corporate partners for deals, and strategic planning and preparation of materials for transactions.
Drug Development Support
Strategic consulting and planning for pharmaceutical product and drug development, assisting biotech companies to structure development plans, control costs, and optimize deliverable results for pharma licensing deals.
Valuation
Financial valuation services utilizing industry-accepted principles, cashflow projections, discounted cashflows, and sensitivity analysis.
Executive Search Services
Specialised executive search and talent acquisition solutions tailored for the life sciences, pharmaceutical, biotech, MedTech, and Digital Health industries.
Pharmaceutical Expert Witness Service
Independent expert witness support and consulting for pharmaceutical and biotechnology litigation, licensing disputes, lost revenues, damages determination, and diligence obligations.
Corporate Deals
Assisting companies in Business Development, identifying partners and products, in-licensing and out-licensing, M&A, R&D collaborations, Financing.
Product Licensing
Services to help companies identify products for licensing, corporate partners for deals, and strategic planning and preparation of materials for transactions.
Drug Development Support
Strategic consulting and planning for pharmaceutical product and drug development, assisting biotech companies to structure development plans, control costs, and optimize deliverable results for pharma licensing deals.
Valuation
Financial valuation services utilizing industry-accepted principles, cashflow projections, discounted cashflows, and sensitivity analysis.
Executive Search Services
Specialised executive search and talent acquisition solutions tailored for the life sciences, pharmaceutical, biotech, MedTech, and Digital Health industries.
Services
Support for sourcing partners, structuring licensing deals, deal negotiation and alliance management.
Fundraising strategy, investor targeting, preparation of investor materials, valuation modelling and introductions to investors.
Identification, screening and presentation of senior executive candidates and onboarding support for portfolio companies.
Strategic planning across discovery, preclinical and clinical stages including development inflection point identification to optimise value and licensing potential.
Market entry planning and management of distributor and licensee relationships to introduce products to new territories.
Independent market research, commercial evaluations, technical due diligence and exit planning support for institutional investors and family offices.
Support for sourcing partners, structuring licensing deals, deal negotiation and alliance management.
Fundraising strategy, investor targeting, preparation of investor materials, valuation modelling and introductions to investors.
Identification, screening and presentation of senior executive candidates and onboarding support for portfolio companies.
Strategic planning across discovery, preclinical and clinical stages including development inflection point identification to optimise value and licensing potential.
Market entry planning and management of distributor and licensee relationships to introduce products to new territories.
Independent market research, commercial evaluations, technical due diligence and exit planning support for institutional investors and family offices.
Expertise Areas
- Business development and licensing
- Capital raising and investor relations
- Product development and clinical strategy
- Due diligence and valuations
Key Technologies
- Financial modelling and valuation methods
- Investor pitch deck and business plan development
- Clinical development planning (Phase I-III strategy)
- Regulatory pathway planning (IND/NDA/MAA)